Wegovy is a GLP-1 agonist containing semaglutide, the same active ingredient as Ozempic. While both medications share this ...

Join a suite of experts from across the industry Jan. 29 for a free online event examining the opportunities and challenges ...

Recent findings indicate that widely used weight-loss medications might lead to muscle loss, including vital heart muscle, ...

Research suggests caffeine can help with weight loss, but a large dose is necessary to create a response. A 2020 review in ...

Ozempic and Wegovy do the same thing as GLP-1 would normally do for you — but to enable them to treat diabetes and obesity, ...

The stock price of the two most prominent players in the diabetes and obesity care market, Novo Nordisk NVO and Eli Lilly LLY ...

Novo Nordisk’s NVO shares lost 5.3% on Friday after Medicare issued a press release selecting the company’s popular ...

“Some folks have to cut their pills in half or skip ... (Novo Nordisk’s semaglutide-based drugs stimulate the GLP-1 hormone.) ...

The government is expected to pay lower prices for Ozempic and Wegovy starting in 2027. The Trump administration will decide ...

It may seem harder to lose weight when you have irritable bowel syndrome (IBS). That's because some of the foods associated with a healthful diet—such as those high in fiber—may aggravate symptoms of ...

although a few pills have emerged; Novo Nordisk sells a pill form of semaglutide, under the brand name Rybelsus, for treating type 2 diabetes. Read More: Ozempic and prescription weight loss drugs ...